“Cellerant is pleased to be working with Progenitor Cell Therapy for the manufacture of our first product, CLT-001, a highly purified hematopoietic stem cell product for the treatment of genetic blood disorders, cancer, and autoimmune disease. PCT's cell-based manufacturing and regulatory expertise should allow us to move quickly towards our goal of treating patients in 2006.”
“Certainly she hasn't announced yet, and she's probably not decided yet, either. The immediate task for her supporters here is to win re-election. That's what everyone is focused on.”
“While we're searching for new ways to treat people, we'd better have the best available evidence on the drugs that are available. This takes us another step along the way.”
